British Journal of Ophthalmology

Systemic and ocular associated factors for pathologic myopia in a highly myopic Chinese population: findings from the Wenzhou pathologic myopia study

Aims This study aimed to explore ocular and systemic factors associated with pathologic myopia in patients with high myopia ...
Healio

Expanding myopia epidemic likely to result in increasing prevalence of pathologic myopia

Please provide your email address to receive an email when new articles are posted on . The expanding myopia epidemic and the increasing number of children who develop myopia at a young age will ...
Medscape

Overnight Orthokeratology Is Comparable With Atropine in Controlling Myopia

Background: Many efforts have been invested in slowing progression of myopia. Among the methods, atropine administration and orthokeratology (OK) are most widely used. This study analyzed the efficacy ...
Medscape

High Dose Atropine Curbs Myopia in Kids Despite Side Effects

According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and axial ...
Kaleido Scope

Optometry professor secures R01 grant to combat myopia epidemic

Timothy Gawne, PhD, FAAO, UAB School of Optometry professor, has been awarded an R01 grant to investigate the growing epidemic of myopia (nearsightedness), a condition affecting over 40 percent of the ...
The American Journal of Managed Care

Atropine 0.01% Not Associated With Slowing Myopia Progression

A study that focused on children aged 5 to 12 years who lived in the United States found no difference between atropine 0.01% and placebo in treating myopia progression. Atropine 0.01% was no more ...